SCHEMBL5658176

SCHEMBL5658176

CNc1nc2sc(OC(C)C)nc2c2c1ncn2C

nearest known ligand 0.64

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ IKBKB O14920 20/20 0.64
▸ CHUK O15111 12/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14589433 0.86 IKBKB (0.69) IKBKBCHUK
SCHEMBL5657598 0.85 IKBKB (0.62) IKBKBCHUK
SCHEMBL5661147 0.84 IKBKB (0.66) IKBKBCHUK
SCHEMBL5656947 0.81 IKBKB (0.63) IKBKBCHUK
SCHEMBL14589422 0.81 IKBKB (0.62) IKBKBCHUK
SCHEMBL14589425 0.80 IKBKB (0.60) IKBKBCHUK
SCHEMBL14589419 0.80 IKBKB (0.64) IKBKBCHUK
SCHEMBL14589417 0.80 IKBKB (0.60) IKBKBCHUK
SCHEMBL5658199 0.80 IKBKB (0.60) IKBKBCHUK
SCHEMBL14589416 0.79 IKBKB (0.60) IKBKBCHUK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7176214-B2 Imidazo-fused oxazolo[4,5-β]pyridine and imidazo-fused thiazolo[4,5-β]pyridine based tricyclic compounds and pharmaceutical compositions comprising same BRISTOL-MYERS SQUIBB COMPANY (US) 2007-02-13 — — US disclosed
US-7176214-B2 Imidazo-fused oxazolo[4,5-β]pyridine and imidazo-fused thiazolo[4,5-β]pyridine based tricyclic compounds and pharmaceutical compositions comprising same BRISTOL-MYERS SQUIBB COMPANY (US) 2007-02-13 — — US disclosed
US-7176214-B2 Imidazo-fused oxazolo[4,5-β]pyridine and imidazo-fused thiazolo[4,5-β]pyridine based tricyclic compounds and pharmaceutical compositions comprising same BRISTOL-MYERS SQUIBB COMPANY (US) 2007-02-13 — — US disclosed
Send feedback